Restrictions lowered for cannabis-derived drug
Sunday, October 7, 2018 - 09:00
in Health & Medicine
DEA reschedules Epidiolex, an FDA-approved cannabidiol treatment for rare seizure disorders
DEA reschedules Epidiolex, an FDA-approved cannabidiol treatment for rare seizure disorders